SilverCrest Reports More High Grade Underground Sampling

New Post Public Reply Private Reply Replies (0) Message Board
Roger Wilco
SilverCrest Reports More High Grade Underground Sampling Results at Las Chispas; Multiple Sample Results Greater than 2,500 gpt AgEq*


TSX V: SIL

IMG_1676.jpg

VANCOUVER , Aug. 18, 2016 /CNW/ - SilverCrest Metals Inc. ("SilverCrest" or the "Company" is pleased to announce an update on the underground rehabilitation program with additional assay results from underground channel sampling at its Las Chispas Project ("Las Chispas" located in Sonora, Mexico . Las Chispas is in a historic silver-gold mining district which presently hosts two nearby precious metal producers. Historic information indicates that only three veins of the fourteen historically reported veins at Las Chispas have had documented production, which occurred between 1880 and 1930. SilverCrest's initial focus is on these three veins; the Las Chispas, William Tell and Babicanora. This news release reports on the sampling assay results of the William Tell vein. For more information on Las Chispas and recent channel sampling and drill results, please refer to our website at:

http://www.silvercrestmetals.com.

N. Eric Fier , CPG, P.Eng, President & CEO commented, "We continue to expand our high grade footprint at Las Chispas with the latest results from the ongoing underground rehabilitation and channel sampling program as we continue to gain further access to historic workings. Our onsite team has safely descended to the historic 650 level** of the William Tell vein with subsequent ongoing mapping and sampling. Our channel sample results on the 650 level are showing sub interval bonanza grades in excess of 2,500 grams per tonne silver equivalent (AgEq)*over 0.20 metre to 1.12 metre widths.

The William Tell vein is located approximately 120 metres west of the Las Chispas vein and is easily accessible by shared access to both veins. The William Tell vein has had less historical production than the Las Chispas vein, for reasons which we believe are due to a fault displacement which resulted in the previous operator mining out only a fraction of the in situ mineralization. Our Phase I drilling program appears to have intercepted the unmined faulted extension of the William Tell vein. Additional drilling will be required to confirm this and determine the extent, if any, of the intercepted mineralization."

Underground Rehabilitation Update


The Company continues to systemically collect channel samples at intervals of two to three metres along strike length as new areas and levels are being explored. In its news releases dated April 28 th and June 09, 2016 , the Company disclosed that it had gained access to the historic 600 level at William Tell and reported results from 79 channel samples. Since then, the Company has collected a total of 39 additional channel samples on the 650 and 450 levels (see attached Figure and Photo). Sampling locations and widths are restricted to historic workings which may only represent part of the mineralized vein, stockwork, or breccia. The location, true thickness and extent of mineralization is indeterminate until adequate drilling is completed at the William Tell vein.

The most significant composited sample results for the William Tell South 650 level average 1.12 metres wide at 3.23 grams per tonne ("gpt" gold and 518 gpt silver, or 760 gpt silver equivalent (AgEq*, uncut, undiluted) over a continuous 21 metre strike length in a developed but unmined area on the 650 level. The most significant un-composited sampling for the William Tell North 450 level averages 2.13m wide at 5.7 gpt gold and 257.7 gpt silver, or 685 gpt silver equivalent (AgEq*, uncut, undiluted) over a continuous 30 metre strike length. Further drilling will help test the true thickness and grade of mineralization in both these areas.

The Company is reviewing the possibility of a controlling, cross-cutting, high grade structural corridor that extends from the Las Chispas vein through the William Tell vein which is potentially 500 metres in length and a minimum of 300 metres in depth (see attached Figure).

To date, approximately 4 kilometres of underground workings have been accessed with an additional 7.5 kilometres to be opened and explored over the next several months. The Company intends to continue with the underground rehabilitation program and reporting results for the remainder of 2016.

Drilling Update

The Company has completed its Phase I surface drill program having drilled 22 core holes for a total of approximately 6,400 metres. A combined 19 holes have been drilled in Las Chispas and William Tell veins, and three holes have been drilled in the La Victoria area located near the Babicanora vein. Upon receipt of further core assays, the Company will compile and integrate the drill results with the underground information, which the Company expects to announce over the next several weeks. Based on positive Phase I surface drilling results, the Company will propose a Phase II surface drill program.

Dependent on permitting completion, the planned 2,000 metre underground drill program should commence in late Q3 or early Q4 2016. The underground drill program will focus on delineation of a potential bulk sample and infill drilling in preparation for the initial Las Chispas resource estimation.

The Qualified Person under National Instrument 43-101 Standards of Disclosure for Mineral Projects for this news release is N. Eric Fier , CPG, P.Eng, and President and CEO for SilverCrest, who has reviewed and approved its contents.

ABOUT SILVERCREST METALS INC.


SilverCrest is a Canadian precious metals exploration company headquartered in Vancouver, BC , that is focused on new discoveries, value-added acquisitions and targeting production in Mexico's historic precious metal districts. The Company is led by a proven management team in all aspects of the precious metal mining sector, including the pioneering of a responsible "phased approach" business model taking projects through discovery, finance, on time and on budget construction, and production with subsequent increased value to shareholders.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading

Top 5 Most Recently Viewed Articles

NVIDIA and Synopsys Forge Alliance to Transform Engineering

Updated Category News Views 137

Strategic Collaboration Between NVIDIA and Synopsys In an exciting development for the engineering and design industries, NVIDIA and Synopsys have joined forces in a strategic partnership that promises to revolutionize how these sectors operate. This collaboration aims to leverage NVIDIA's powerful computational capabilities alongside Synopsys' sophisticated engineering...

Continue Reading
EHang's Groundbreaking Pilotless Flight Marks a Historic Event

Updated Category News Views 110

EHang's Historic Pilotless Flight in Africa EHang Holdings Limited (Nasdaq: EH), a frontrunner in Urban Air Mobility (UAM), has made headlines by achieving a remarkable milestone: the first pilotless human-carrying flight of its EH216-S eVTOL aircraft in Africa. This significant event unfolded at the 9th Aviation Africa Summit in Kigali, marking a historic moment for the...

Continue Reading
Bang & Olufsen's Share Buyback: Strategic Moves for Growth

Updated Category News Views 112

Understanding Bang & Olufsen's Share Buyback Program Bang & Olufsen A/S has embarked on a significant initiative aimed at bolstering its long-term growth through its recent share buyback program. This strategic move is designed to hedge the company’s share-based long-term incentive programmes, showcasing their commitment to enhancing shareholder value. This article...

Continue Reading
Johnson & Johnson's Q2 Expectations and Analyst Ratings Insights

Updated Category News Views 275

Upcoming Earnings Announcement for Johnson & Johnson Johnson & Johnson (NYSE: JNJ) is preparing to disclose its earnings results for the upcoming second quarter. Analysts are closely watching the anticipated report, which is expected to provide valuable insights into the company's financial health. Expected Financial Performance Analyst forecasts suggest that Johnson &...

Continue Reading
Safe House Project Expands Impact with ATI Acquisition

Updated Category News Views 307

Safe House Project Expands Impact with ATI Acquisition This Giving Tuesday, the Safe House Project (SHP) shared exciting news about its acquisition of Anti-Trafficking International (ATI), an organization that has been pivotal in the fight against human trafficking. By incorporating ATI's respected practices and its renowned Just Ask Prevention Curriculum, SHP aims to...

Continue Reading